The tissue distribution of nucleobindin-2/nesfatin-1 in the reproductive organs of bitches with regard to the animal’s age and body weight
References
- Ademoglu E.N., Gorar S., Carlıoglu A., Yazıcı H., Dellal F.D., Berberoglu Z., Akdeniz D., Uysal S., Karakurt F.: Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome. J Endocrinol Invest 2014, 37, 715–719, doi: 10.1007/s40618-014-0089-2.
- Alp E., Görmüş U., Güdücü N., Bozkurt S.: Nesfatin-1 levels and metabolic markers in polycystic ovary syndrome. Gynecol Endocrinol 2015, 31, 543–547, doi: 10.3109/09513590.2015.1024219.
- Banerjee S., Chaturvedi C.M.: Nesfatin-1: localization and expression in avian gonads and its modulation by temporal phase relation of neural oscillations in female Japanese quail,
Coturnix coturnix japonica . Gen Comp Endocrinol 2015, 224, 205–215, doi: 10.1016/j.ygcen.2015.08.016. - Cao Z., Luo L., Yang J., Zhang L., Gao D., Xu T., Tong X., Zhang D., Wang Y., Li Y., Fang F., Zhang Y.: Stimulatory effects of nesfatin-1 on meiotic and developmental competence of porcine oocytes. J Cell Physiol 2019, 234, 17767–17774, doi: 10.1002/jcp.28402.
- Ciccimarra R., Bussolati S., Grasselli F., Grolli S., Paolucci M., Basini G.: Potential physiological involvement of nesfatin-1 in regulating swine granulosa cell functions. Reprod Fertil Dev 2020, 32, 274, doi: 10.1071/RD19134.
- Deniz R., Gurates B., Aydin S., Celik H., Sahin İ., Baykus Y., Catak Z., Aksoy A., Citil C., Gungor S.: Nesfatin-1 and other hormone alterations in polycystic ovary syndrome. Endocrine 2012, 42, 694–699, doi: 10.1007/s12020-012-9638-7.
- Gao X., Zhang K., Song M., Li X., Luo L., Tian Y., Zhang Y., Li Y., Zhang X., Lin Y., Fang F., Liu Y.: Role of nesfatin-1 in the reproductive axis of male rat. Sci Rep 2016, 6, 32877, doi: 10.1038/srep32877.
- Garcés M.F., Poveda N.E., Sanchez E., Sánchez Á.Y., Bravo S.B., Vázquez M.J., Diéguez C., Nogueiras R., Caminos J.E.: Regulation of NucB2/Nesfatin-1 throughout rat pregnancy. Physiol Behav 2014, 133, 216–222, doi: 10.1016/j.physbeh.2014.05.042.
- Gonzalez R., Reingold B.K., Gao X., Gaidhu M.P., Tsushima R., Unniappan S.: Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet beta and min6 cells. J Endocrinol 2011, 208, R9–R16, doi: 10.1530/JOE-10-0492.
- Gonzalez R., Shepperd E., Thiruppugazh V., Lohan S., Grey C.L., Chang J.P., Unniappan S.: Nesfatin-1 regulates the hypothalamo-pituitary-ovarian axis of fish. Biol Reprod 2012, 87, 1–11, doi: 10.1095/biolreprod.112.099630.
- Hatef A., Unniappan S.: Gonadotropin-releasing hormone, kisspeptin, and gonadal steroids directly modulate nucleobindin-2/nesfatin-1 in murine hypothalamic gonadotropin-releasing hormone neurons and gonadotrophs. Biol Reprod 2017, 96, 635–651, doi: 10.1095/biolreprod.116.146621.
- Ibrahim M.N., Attia K.I., Habib M.A., Roshdy D.A.: Effect of sex hormones on serum levels of nesfatin-1 in experimental rats. Med J Cairo Univ 2019, 87, 421–428, doi: 10.21608/mjcu.2019.52364.
- Kim J., Chung Y., Kim H., Im E., Lee H., Yang H.: The tissue distribution of nesfatin-1/NUCB2 in mouse. Dev Reprod 2014, 18, 301–309, doi: 10.12717/DR.2014.18.4.301.
- Kim J., Sun S., Lee D., Youk H., Yang H.: Gonadotropin regulates NUCB2/nesfatin-1 expression in the mouse ovary and uterus. Biochem Biophys Res Commun 2019, 513, 602–607, doi: 10.1016/j.bbrc.2019.04.008.
- Kim J., Yang H.: Nesfatin-1 as a new potent regulator in reproductive system. Dev Reprod 2012, 16, 253–264, doi: 10.12717/DR.2012.16.4.253.
- Kucukler F.K., Gorkem U., Simsek Y., Kocabas R., Gulen S., Guler S.: Low level of nesfatin-1 is associated with gestational diabetes mellitus. Gynecol Endocrinol 2016, 32, 759–761, doi: 10.1080/09513590.2016.1180679.
- Kulinska K.I., Andrusiewicz M., Dera-Szymanowska A., Billert M., Skrzypski M., Szymanowski K., Nowak-Markwitz E., Kotwicka M., Wołuń-Cholewa M.: Phoenixin as a new target in the development of strategies for endometriosis diagnosis and treatment. Biomedicines 2021, 9, 1–12, doi: 10.3390/biomedicines9101427.
- Markowska A., Szarszewska M., Knapp P., Grybos A., Grybos M., Marszalek A., Filas V., Wojcik-Krowiranda K., Swornik M., Markowska J.: The role of nesfatin and selected molecular factors in various types of endometrial cancer. Ginekol Pol 2019, 90, 571–576, doi: 10.5603/GP.2019.0099.
- Nozawa S., Kimura T., Kurishima M., Mimura K., Saeki K., Miki Y., Oda H., Mori A., Momota Y., Azakami D., Ishioka K.: Analyses of a satiety factor NUCB2/nesfatin-1, gene expressions and modulation by different dietary components in dogs. J Vet Med Sci 2016, 78, 411–417, doi: 10.1292/jvms.15-0255.
- Oh-I S., Shimizu H., Satoh T., Okada S., Adachi S., Inoue K., Eguchi H., Yamamoto M., Imaki T., Hashimoto K., Tsuchiya T., Monden T., Horiguchi K., Yamada M., Mori M.: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006, 443, 709–712, doi: 10.1038/nature05162.
- Osiak-Wicha C., Kras K., Tomaszewska E., Muszyński S., Arciszewski M.B.: Examining the potential applicability of orexigenic and anorexigenic peptides in veterinary medicine for the management of obesity in companion animals. Curr Issues Mol Biol 2024, 46, 6725–6745, doi: 10.3390/cimb46070401.
- Pałasz A., Rojczyk E., Bogus K., Worthington J.J., Wiaderkiewicz R.: The novel neuropeptide phoenixin is highly co-expressed with nesfatin-1 in the rat hypothalamus, an immunohistochemical study. Neurosci Lett 2015, 592, 17–21, doi: 10.1016/j.neulet.2015.02.060.
- Parlak Ak T., Yaman M., Bayrakdar A., Bulmus O.: Expression of phoenixin-14 and nesfatin-1 in the hypothalamo–pituitary–gonadal axis in the phases of the estrous cycle. Neuropeptides 2023, 97, 102299, doi: 10.1016/j.npep.2022.102299.
- Ramanjaneya M., Chen J., Brown J.E., Tripathi G., Hallschmid M., Patel S., Kern W., Hillhouse E.W., Lehnert H., Tan B.K., Randeeva H.S.: Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 2010, 151, 3169–3180, doi: 10.1210/en.2009-1358.
- Rupp S.K., Wölk E., Stengel A.: Nesfatin-1 receptor: distribution, signaling and increasing evidence for a G protein-coupled receptor – a systematic review. Front Endocrinol 2021, 12, 1–14, doi: 10.3389/fendo.2021.740174.
- Rybska M., Billert M., Skrzypski M., Kubiak M., Woźna-Wysocka M., Łukomska A., Nowak T., Błaszczyk-Cichoszewska J., Pomorska-Mól M., Wąsowska B.: Canine cystic endometrial hyperplasia and pyometra may downregulate neuropeptide phoenixin and gpr173 receptor expression. Anim Reprod Sci 2022, 238, 106931, doi: 10.1016/j.anireprosci.2022.106931.
- Rybska M., Billert M., Skrzypski M., Wojciechowicz T., Kubiak M., Łukomska A., Nowak T., Włodarek J., Wąsowska B.: Expression and localization of the neuropeptide phoenixin-14 and its receptor grp173 in the canine reproductive organs and periovarian adipose tissue. Anim Reprod Sci 2023, 255, 107282, doi: 10.1016/j.anireprosci.2023.107282.
- Rybska M., Skrzypski M., Billert M., Wojciechowicz T., Łukomska A., Pawlak P., Nowak T., Pusiak K., Wąsowska B.: Nesfatin-1 expression and blood plasma concentration in female dogs suffering from cystic endometrial hyperplasia and pyometra and its possible interaction with phoenixin-14. BMC Vet Res 2024 20, 486, doi: 10.1186/s12917-024-04336-w.
- Schalla M.A., Stengel A.: Current understanding of the role of nesfatin-1. J Endocr Soc 2018, 2, 1188–1206, doi: 10.1210/js.2018-00246.
- Schalla M.A., Stengel A.: The role of the gastric hormones ghrelin and nesfatin-1 in reproduction. Int J Mol Sci 2021, 22, 1–36, doi: 10.3390/ijms222011059.
- Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B., Tinevez J.-Y., White D.J., Hartenstein V., Eliceiri K., Tomancak P., Cardona A.: Fiji: an open-source platform for biological-image analysis. Nat Methods 2012, 9, 676–682, doi: 10.1038/nmeth.2019.
- Schmittgen T., Livak K.: Analyzing real-time PCR data by the comparative
C T method. Nat Protoc 2008, 3, 1101–1108, doi: 10.1038/nprot.2008.73. - Şengül Ö., Dilbaz B., Halıcı Z., Ferah I., Çadırcı E., Yılmaz F.: Decreased serum nesfatin-1 levels in endometriosis. Eur J Obstet Gynecol Reprod Biol 2014, 177, 34–37, doi: 10.1016/j.ejogrb.2014.03.012.
- Seon S., Jeon D., Kim H., Chung Y., Choi N., Yang H.: Testosterone regulates NUCB2 mRNA expression in male mouse hypothalamus and pituitary gland. Dev Reprod 2017, 21, 71–78, doi: 10.12717/DR.2017.21.1.071.
- Shimizu H., Oh-I S., Okada S., Mori M.: Nesfatin-1: An overview and future clinical application. Endocr J 2009, 56, 537–543, doi: 10.1507/endocrj.K09E-117.
- Small C.J., Stanley S.A., Bloom S.R.: Appetite control and reproduction: leptin and beyond. Semin Reprod Med 2002, 20, 389–398, doi: 10.1055/s-2002-36712.
- Sun S., Shin J., Jang J., Hwang S., Kim J., Kong J., Yang H.: 17Beta-estradiol regulates NUCB2/nesfatin-1 expression in mouse oviduct. Dev Reprod 2020, 24, 43–52, doi: 10.12717/DR.2020.24.1.43.
- Tagaya Y., Osaki A., Miura A., Okada S., Ohshima K., Hashimoto K., Yamada M., Satoh T., Shimizu H., Mori M.: Secreted nucleobindin-2 inhibits 3t3-l1 adipocyte differentiation. Protein Pept Lett 2012, 19, 997–1004, doi: 10.2174/092986612802084546.
- Takagi K., Miki Y., Tanaka S., Hashimoto C., Watanabe M., Sasano H., Ito K., Suzuki T.: Nucleobindin 2 (NUCB2) in human endometrial carcinoma: A Potent Prognostic Factor Associated with Cell Proliferation and Migration. Endocr J 2016, 63, 287–299, doi: 10.1507/endocrj.EJ15-0490.
- Tekin T., Cicek B., Konyaligil N.: Regulatory peptide nesfatin-1 and its relationship with metabolic syndrome. Eurasian J Med 2019, 51, 280–284, doi: 10.5152/eurasianjmed.2019.18420.
- Wang M., Tong J., Zhu Q., Tang H., Tang L.: Blood nesfatin-1 levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol 2024, 14, 1275753, doi: 10.3389/fendo.2023.1275753.
- Weibert E., Hofmann T., Stengel A.: Role of nesfatin-1 in anxiety, depression and the response to stress. Psychoneuroendocrinology 2019, 100, 58–66, doi: 10.1016/j.psyneuen.2018.09.037.
- Wu C., Lin F., Qiu S., Jiang Z.: The characterization of obese polycystic ovary syndrome rat model suitable for exercise intervention. PLoS One 2014, 9, e99155, doi: 10.1371/journal.pone.0099155.
- Zhang C., Wang Y., Wang Y., Li J., Liu R., Liu H.: Decreased levels of serum nesfatin-1 in patients with preeclampsia. Biomarkers 2014, 19, 402–406, doi: 10.3109/1354750X.2014.919027.
DOI: https://doi.org/10.2478/jvetres-2025-0015 | Journal eISSN: 2450-8608
Language: English
Page range: 141 - 150
Submitted on: Aug 18, 2024
Accepted on: Mar 10, 2025
Published on: Mar 25, 2025
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2025 Marta Rybska, Marek Skrzypski, Karolina Pusiak, Tatiana Wojciechowicz, Adam Mieldzioc, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution 4.0 License.